National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 270263

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2007

VAERS ID: 270263
Age:17.0
Gender:Female
Location:Georgia
Vaccinated:2006-10-10
Onset:0000-00-00
Submitted:2007-01-05
Entered:2007-01-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - - / -
MNQ: MENINGOCOCCAL (MENACTRA) / AVENTIS PASTEUR - / - - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Alopecia, Attention deficit/hyperactivity disorder, Eating disorder

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: (therapy unspecified)
Current Illness:
Preexisting Conditions: eating disorder, attention deficit/hyperactivity disorder
Diagnostic Lab Data: UNK
CDC 'Split Type':

Write-up:Information has been received from a licensed practical nurse concerning a 17 year old female with an eating disorder and attention deficit/hyperactivity disorder who on 10 Oct 2006, was vaccinated with a dose of Gardasil. The patient was concomitantly va"ccinated with a dose of Menactra. Concomitant therapy included unspecified therapy for ADHD. Subsequently, the patient experienced thinning of hair/alopecia. The patient sought unspecified medical attention. At the time of this report, the patient had not


Changed on 12/8/2009

VAERS ID: 270263 Before After
Age:17.0
Gender:Female
Location:Georgia
Vaccinated:2006-10-10
Onset:0000-00-00
Submitted:2007-01-05
Entered:2007-01-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - - / -
MNQ: MENINGOCOCCAL (MENACTRA) / AVENTIS PASTEUR - / - - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Alopecia, Attention deficit/hyperactivity disorder, Eating disorder

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: (therapy unspecified)
Current Illness:
Preexisting Conditions: eating disorder, attention deficit/hyperactivity disorder
Diagnostic Lab Data: UNK
CDC 'Split Type': (blank) WAES0612USA01067

Write-up:Information has been received from a licensed practical nurse concerning a 17 year old female with an eating disorder and attention deficit/hyperactivity disorder who on 10 Oct 2006, was vaccinated with a dose of Gardasil. The patient was concomitantly va"ccinated vaccinated with a dose of Menactra. Concomitant therapy included unspecified therapy for ADHD. Subsequently, the patient experienced thinning of hair/alopecia. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Additional information has been requested.


Changed on 2/5/2010

VAERS ID: 270263 Before After
Age:17.0
Gender:Female
Location:Georgia
Vaccinated:2006-10-10
Onset:0000-00-00
Submitted:2007-01-05
Entered:2007-01-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - - / -
MNQ: MENINGOCOCCAL (MENACTRA) / AVENTIS PASTEUR SANOFI PASTEUR - / - - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Alopecia, Attention deficit/hyperactivity disorder, Eating disorder

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: (therapy unspecified)
Current Illness:
Preexisting Conditions: eating disorder, attention deficit/hyperactivity disorder
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0612USA01067

Write-up:Information has been received from a licensed practical nurse concerning a 17 year old female with an eating disorder and attention deficit/hyperactivity disorder who on 10 Oct 2006, was vaccinated with a dose of Gardasil. The patient was concomitantly vaccinated with a dose of Menactra. Concomitant therapy included unspecified therapy for ADHD. Subsequently, the patient experienced thinning of hair/alopecia. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Additional information has been requested.


Changed on 4/7/2010

VAERS ID: 270263 Before After
Age:17.0
Gender:Female
Location:Georgia
Vaccinated:2006-10-10
Onset:0000-00-00
Submitted:2007-01-05
Entered:2007-01-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - - UN / - IM
MNQ: MENINGOCOCCAL (MENACTRA) MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / - - UN / - UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Alopecia, Attention deficit/hyperactivity disorder, Eating disorder

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: (therapy unspecified) ADDERALL XR
Current Illness: Attention deficit/hyperactivity disorder; Bulimia
Preexisting Conditions: eating disorder, attention deficit/hyperactivity disorder
Diagnostic Lab Data: UNK Diagnostic laboratory, CMP within normal limits; diagnostic laboratory, WESR within normal limits; diagnostic laboratory, pre albumin within normal limits; complete blood cell, within normal limits; serum C-reactive protein, within normal l
CDC 'Split Type': WAES0612USA01067

Write-up:Information has been received from a licensed practical nurse concerning a 17 year old female with an eating disorder and attention deficit/hyperactivity disorder who on 10 Oct 2006, was vaccinated with a dose of Gardasil. The patient was concomitantly vaccinated with a dose of Menactra. Concomitant therapy included unspecified therapy for ADHD. Subsequently, the patient experienced thinning of hair/alopecia. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/5/2007. Information has been received from a licensed practical nurse concerning a 17 year old female student with bulima and attention deficit/hyperacticity disorder who on 15-SEP-2006 (previously reported as 10-OCT-2006), was vaccinated intramuscularly with a 0.5 mL dose of GARDASIL (lot 653735/0688F). The patient was concomitantly vaccinated with a dose of MENACTRA. Concomitant therapy included ADDERALL XR. Subsequently, the patient experienced thinning of hair/alopecia. The patient was seen in the office and thinning hair was noted. Laboratory evaluations revealed that CMP, complete blood count, thyroid stimulating hormone, c-reactive protein, WESR, and pre-albumin were all within normal limits. It was reported that the physician was having the patient monitor the condition. At the time of this report, the patient had not recovered. No additional information is expected.


Changed on 7/31/2010

VAERS ID: 270263 Before After
Age:17.0
Gender:Female
Location:Georgia
Vaccinated:2006-10-10
Onset:0000-00-00
Submitted:2007-01-05
Entered:2007-01-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - UN / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / - UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Alopecia, Attention deficit/hyperactivity disorder, Blood albumin normal, Blood thyroid stimulating hormone, C-reactive protein normal, Eating disorder, Full blood count normal, Red blood cell sedimentation rate normal, Metabolic function test

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ADDERALL XR
Current Illness: Attention deficit/hyperactivity disorder; Bulimia
Preexisting Conditions:
Diagnostic Lab Data: Diagnostic laboratory, CMP within normal limits; diagnostic laboratory, WESR within normal limits; diagnostic laboratory, pre albumin within normal limits; complete blood cell, within normal limits; serum C-reactive protein, within normal l
CDC 'Split Type': WAES0612USA01067

Write-up:Information has been received from a licensed practical nurse concerning a 17 year old female with an eating disorder and attention deficit/hyperactivity disorder who on 10 Oct 2006, was vaccinated with a dose of Gardasil. The patient was concomitantly vaccinated with a dose of Menactra. Concomitant therapy included unspecified therapy for ADHD. Subsequently, the patient experienced thinning of hair/alopecia. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/5/2007. Information has been received from a licensed practical nurse concerning a 17 year old female student with bulima and attention deficit/hyperacticity disorder who on 15-SEP-2006 (previously reported as 10-OCT-2006), was vaccinated intramuscularly with a 0.5 mL dose of GARDASIL (lot 653735/0688F). The patient was concomitantly vaccinated with a dose of MENACTRA. Concomitant therapy included ADDERALL XR. Subsequently, the patient experienced thinning of hair/alopecia. The patient was seen in the office and thinning hair was noted. Laboratory evaluations revealed that CMP, complete blood count, thyroid stimulating hormone, c-reactive protein, WESR, and pre-albumin were all within normal limits. It was reported that the physician was having the patient monitor the condition. At the time of this report, the patient had not recovered. No additional information is expected.


Changed on 1/4/2011

VAERS ID: 270263 Before After
Age:17.0
Gender:Female
Location:Georgia
Vaccinated:2006-10-10
Onset:0000-00-00
Submitted:2007-01-05
Entered:2007-01-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - UN / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / - UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Alopecia, Attention deficit/hyperactivity disorder, Blood albumin normal, Blood thyroid stimulating hormone, C-reactive protein normal, Eating disorder, Full blood count normal, Red blood cell sedimentation rate normal, Metabolic function test

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ADDERALL XR
Current Illness: Attention deficit/hyperactivity disorder; Bulimia
Preexisting Conditions:
Diagnostic Lab Data: Diagnostic laboratory, CMP within normal limits; diagnostic laboratory, WESR within normal limits; diagnostic laboratory, pre albumin within normal limits; complete blood cell, within normal limits; serum C-reactive protein, within normal l limits; serum TSH, within normal limits
CDC 'Split Type': WAES0612USA01067

Write-up:Information has been received from a licensed practical nurse concerning a 17 year old female with an eating disorder and attention deficit/hyperactivity disorder who on 10 Oct 2006, was vaccinated with a dose of Gardasil. The patient was concomitantly vaccinated with a dose of Menactra. Concomitant therapy included unspecified therapy for ADHD. Subsequently, the patient experienced thinning of hair/alopecia. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/5/2007. Information has been received from a licensed practical nurse concerning a 17 year old female student with bulima and attention deficit/hyperacticity disorder who on 15-SEP-2006 (previously reported as 10-OCT-2006), was vaccinated intramuscularly with a 0.5 mL dose of GARDASIL (lot 653735/0688F). The patient was concomitantly vaccinated with a dose of MENACTRA. Concomitant therapy included ADDERALL XR. Subsequently, the patient experienced thinning of hair/alopecia. The patient was seen in the office and thinning hair was noted. Laboratory evaluations revealed that CMP, complete blood count, thyroid stimulating hormone, c-reactive protein, WESR, and pre-albumin were all within normal limits. It was reported that the physician was having the patient monitor the condition. At the time of this report, the patient had not recovered. No additional information is expected.


Changed on 6/14/2014

VAERS ID: 270263 Before After
Age:17.0
Gender:Female
Location:Georgia
Vaccinated:2006-10-10
Onset:0000-00-00
Submitted:2007-01-05
Entered:2007-01-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - UN / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / - UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Alopecia, Attention deficit/hyperactivity disorder, Blood albumin normal, Blood thyroid stimulating hormone, C-reactive protein normal, Eating disorder, Full blood count normal, Red blood cell sedimentation rate normal, Metabolic function test

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ADDERALL XR
Current Illness: Attention deficit/hyperactivity disorder; Bulimia
Preexisting Conditions:
Diagnostic Lab Data: Diagnostic laboratory, CMP within normal limits; diagnostic laboratory, WESR within normal limits; diagnostic laboratory, pre albumin within normal limits; complete blood cell, within normal limits; serum C-reactive protein, within normal limits; serum TSH, within normal limits
CDC 'Split Type': WAES0612USA01067

Write-up:Information has been received from a licensed practical nurse concerning a 17 year old female with an eating disorder and attention deficit/hyperactivity disorder who on 10 Oct 2006, was vaccinated with a dose of Gardasil. The patient was concomitantly vaccinated with a dose of Menactra. Concomitant therapy included unspecified therapy for ADHD. Subsequently, the patient experienced thinning of hair/alopecia. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/5/2007. Information has been received from a licensed practical nurse concerning a 17 year old female student with bulima and attention deficit/hyperacticity disorder who on 15-SEP-2006 (previously reported as 10-OCT-2006), was vaccinated intramuscularly with a 0.5 mL dose of GARDASIL (lot 653735/0688F). The patient was concomitantly vaccinated with a dose of MENACTRA. Concomitant therapy included ADDERALL XR. Subsequently, the patient experienced thinning of hair/alopecia. The patient was seen in the office and thinning hair was noted. Laboratory evaluations revealed that CMP, complete blood count, thyroid stimulating hormone, c-reactive protein, WESR, and pre-albumin were all within normal limits. It was reported that the physician was having the patient monitor the condition. At the time of this report, the patient had not recovered. No additional information is expected.


Changed on 5/14/2017

VAERS ID: 270263 Before After
Age:17.0
Gender:Female
Location:Georgia
Vaccinated:2006-10-10
Onset:0000-00-00
Submitted:2007-01-05
Entered:2007-01-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - UN / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / - UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Alopecia, Attention deficit/hyperactivity disorder, Blood albumin normal, Blood thyroid stimulating hormone, C-reactive protein normal, Eating disorder, Full blood count normal, Red blood cell sedimentation rate normal, Metabolic function test

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ADDERALL XR
Current Illness: Attention deficit/hyperactivity disorder; Bulimia
Preexisting Conditions:
Diagnostic Lab Data: Diagnostic laboratory, CMP within normal limits; diagnostic laboratory, WESR within normal limits; diagnostic laboratory, pre albumin within normal limits; complete blood cell, within normal limits; serum C-reactive protein, within normal limits; serum TSH, within normal limits
CDC 'Split Type': WAES0612USA01067

Write-up:Information has been received from a licensed practical nurse concerning a 17 year old female with an eating disorder and attention deficit/hyperactivity disorder who on 10 Oct 2006, was vaccinated with a dose of Gardasil. The patient was concomitantly vaccinated with a dose of Menactra. Concomitant therapy included unspecified therapy for ADHD. Subsequently, the patient experienced thinning of hair/alopecia. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/5/2007. Information has been received from a licensed practical nurse concerning a 17 year old female student with bulima and attention deficit/hyperacticity disorder who on 15-SEP-2006 (previously reported as 10-OCT-2006), was vaccinated intramuscularly with a 0.5 mL dose of GARDASIL (lot 653735/0688F). The patient was concomitantly vaccinated with a dose of MENACTRA. Concomitant therapy included ADDERALL XR. Subsequently, the patient experienced thinning of hair/alopecia. The patient was seen in the office and thinning hair was noted. Laboratory evaluations revealed that CMP, complete blood count, thyroid stimulating hormone, c-reactive protein, WESR, and pre-albumin were all within normal limits. It was reported that the physician was having the patient monitor the condition. At the time of this report, the patient had not recovered. No additional information is expected.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=270263&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166